IKZF1 and Miyoshi myopathy: Similarly, in the study by Pourabdollah et al., low IKZF1 and IKZF3 levels correlated with shorter PFS and overall survival (OS), as evidenced by immunohistochemistry of bone marrow from patients with relapsed/refractory MM who were treated with lenalidomide9.